March 2023

Emerging Innovations in Psychedelic Healthcare

The psychedelic healthcare industry is expected to be worth US$5 billion by 2028

Emerging Innovations in Psychedelic Healthcare

In March, at this exclusive invite-only event, meet industry leaders to learn about innovations in psychedelic medicines and market inflection points through open panel discussions, fireside interviews and facilitated networking.

Meet the most sought-after industry leaders face-to-face to learn about innovations in psychedelic medicine, through Q&A sessions and personal meetings.

PSYCH has hand selected industry CEOs and thought leaders to provide comprehensive insights into psychedelic healthcare.


*Psychedelic medicines for addiction disorders

*Training therapists to deliver psychedelic healthcare

*Market consolidation and M&As in psychedelic medicine

*The UK as an epicentre for psychedelic research

For more information and sponsorship opportunities, please email

Looking for Exposure?

Apply to partner with PSYCH and showcase your organisation.
  • Participation in the panel discussion on critical industry talking points
  • Present your company in a fireside interview with top-tier financial media
  • A featured article in The Psychedelic Newsletter - sent to 25000 subscribers
  • Two complimentary tickets and facilitated networking opportunities

Looking to Attend?

Invite only, please register your interest
  • Discover investment opportunities and solutions to mitigate industry bottlenecks
  • Connect with CEOs from leading psychedelic healthcare companies


The inaugural PSYCH Symposium was a sold out event, with decision makers converging to unlock the industry’s potential.

Europe’s leading psychedelic healthcare conference will return to London On Thursday, 6 July.

Ticket registration